Tulane awarded $3.5 million to study how killer immune cells prevent birth defects
July 25, 2022
Over half the population carries a herpesvirus that doesn’t cause any symptoms. It’s so common that physicians don’t routinely screen for it, not even during pregnancy. But of those individuals who contract the virus during pregnancy, nearly a third...
Tulane researchers receive American Heart Association grant to study COVID’s vascular effects
April 25, 2022
The American Heart Association has awarded Tulane University researchers $940,000 to study how COVID-19 spurs vascular inflammation that may increase risks for blood clots and lingering symptoms of long COVID.
The grant is one of 11 recently...
Tulane study shows COVID-19’s lingering impacts on the brain
April 01, 2022
COVID-19 patients commonly report having headaches, confusion and other neurological symptoms, but doctors don’t fully understand how the disease targets the brain during infection.
Now, researchers at Tulane University have shown in detail how...
Could a common virus be a barrier to curing HIV? Tulane University awarded $4.1 million to find out
March 09, 2022
Researchers at Tulane University will use a new $4.1 million grant from the National Institutes of Health to investigate how a common virus may help HIV persist in viral reservoirs and out of reach of leading antiretroviral therapies.
These viral...
Could long-dead bacteria be the culprit behind lingering Lyme symptoms?
January 26, 2022
Even after antibiotic treatment, some Lyme disease patients suffer from an array of symptoms including neurological issues that greatly diminish their quality of life. Brain scans of these patients show persistent neuroinflammation, but the cause...
Annual Faculty Synergy Research Event celebrates collaboration and achievements
December 20, 2021
Sharing ideas that facilitate the discovery of answers to important questions can be an essential part of scientific research. On Tuesday, Dec. 7, the spirit of collaboration and the achievements of Tulane researchers were celebrated at the 12th...
Award recipients from Tulane Faculty Research Synergy Event
December 13, 2021
The following awards were handed out at the Synergy Faculty Research event, hosted by the School of Medicine and held on Dec. 7, 2021.
School of Medicine (SOM) Outstanding Achievements
Largest Funded Research Awards
Tony Ye Hu, PhD
Department of...
Tulane researchers examine relationship between viral dose and COVID-19 severity
November 09, 2021
Over the course of the COVID-19 pandemic, scientists have strived to answer basic questions about the amount of SARS-CoV-2 virus required to cause an infection and how that viral dose influences disease severity. Answers to these questions help...
Tulane University researcher awarded $4.1 million to study impact of malaria, HIV co-infection in pregnant women
October 25, 2021
More than 38 million people worldwide currently live with HIV and among them are women who become infected with malaria during pregnancy. These women and their fetuses tend to have very poor health outcomes, but the specific mechanism for how these...
Tulane University researcher selected to serve on federal Tick-Borne Disease Working Group
August 26, 2021
The U.S. Department of Health and Human Services has selected Tulane University researcher Monica Embers, associate professor of microbiology and immunology, to serve as one of 14 members of the 2021 Tick-Borne Disease Working Group.
The Working...
The Steven & Alexandra Cohen Foundation grants funding for Bartonella Research Consortium
July 14, 2021
Key infectious disease researchers at Tulane University, Duke University and North Carolina State University will collaborate on an initiative to develop a treatment for bartonelloses, a spectrum of vector-borne diseases that can cause debilitating...
Study finds evidence of persistent Lyme infection in brain despite aggressive antibiotic therapy
May 17, 2021
Tulane University researchers found the bacterium that causes Lyme disease in the brain tissue of a woman who had long suffered neurocognitive impairment after her diagnosis and treatment for the tick-borne disease. The presence of the corkscrew-...
Study determines how to best enhance protection of new COVID-19 vaccine
April 21, 2021
A new study co-authored by researchers at Tulane National Primate Research Center found that a vaccine currently being developed induces a robust and long-lasting immune response against SARS-CoV-2, the virus that causes COVID-19, in nonhuman...
Researchers unravel what makes someone a COVID-19 super-spreader
February 09, 2021
Scientists and public health experts have long known that certain individuals, termed “super-spreaders,” can transmit COVID-19 with incredible efficiency and devastating consequences.
Now, researchers at Tulane University, Harvard University, MIT...
Tulane University to lead national research partnership to speed up COVID-19 vaccines and drug discoveries
February 03, 2021
The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine...
